[Controlled trials on the use of thiamphenicol glycinate and acetylcysteine. Mucoelastographic tests and clinico-therapeutic trials].

G. Morandini,G. Damonte,M. Finiguerra,R. Caruso

Abstract:

What problem does this paper attempt to address?

Epidemiological patterns of asbestos exposure and spatial clusters of incident cases of malignant mesothelioma from the Italian national registry

Marisa Corfiati,Alberto Scarselli,Alessandra Binazzi,Davide Di Marzio,Marina Verardo,Dario Mirabelli,Valerio Gennaro,Carolina Mensi,Gert Schallemberg,Enzo Merler,Corrado Negro,Antonio Romanelli,Elisabetta Chellini,Stefano Silvestri,Mario Cocchioni,Cristiana Pascucci,Fabrizio Stracci,Elisa Romeo,Luana Trafficante,Italo Angelillo,Simona Menegozzo,Marina Musti,Domenica Cavone,Gabriella Cauzillo,Federico Tallarigo,Rosario Tumino,Massimo Melis,Sergio Iavicoli,Alessandro Marinaccio,ReNaM Working Group,E Detragiache,F Merletti,M Gangemi,A Stura,C Brentisci,G Diglio,V Macerata,M Gilardetti,L Benfatto,M Bianchelli,G Mazzucco,D Consonni,A Pesatori,L Riboldi,V Bressan,F Gioffre,M Ballarin,C Chermaz,P De Michieli,L Mangone,C Storchi,O Sala,S Silvestri,A Badiali,V Cacciarini,L Giovannetti,A Martini,R Calisti,F La Rosa,D D'Alo,M Petrucci,M Davoli,F Forastiere,F Cavariani,V Ascoli,L Ancona,A Di Giammarco,M Canfora,M Santoro,F Viscardi,A Brangi,V Cozza,A Baldassarre,L Convertini,S Lio,C Nicita,G Dardanoni,S Scondotto,V Nieddu,M Pergola,S Stecchi

DOI: https://doi.org/10.1186/s12885-015-1301-2

IF: 4.638

2015-04-15

BMC Cancer

Abstract:Background: Previous ecological spatial studies of malignant mesothelioma cases, mostly based on mortality data, lack reliable data on individual exposure to asbestos, thus failing to assess the contribution of different occupational and environmental sources in the determination of risk excess in specific areas. This study aims to identify territorial clusters of malignant mesothelioma through a Bayesian spatial analysis and to characterize them by the integrated use of asbestos exposure information retrieved from the Italian national mesothelioma registry (ReNaM). Methods: In the period 1993 to 2008, 15,322 incident cases of all-site malignant mesothelioma were recorded and 11,852 occupational, residential and familial histories were obtained by individual interviews. Observed cases were assigned to the municipality of residence at the time of diagnosis and compared to those expected based on the age-specific rates of the respective geographical area. A spatial cluster analysis was performed for each area applying a Bayesian hierarchical model. Information about modalities and economic sectors of asbestos exposure was analyzed for each cluster. Results: Thirty-two clusters of malignant mesothelioma were identified and characterized using the exposure data. Asbestos cement manufacturing industries and shipbuilding and repair facilities represented the main sources of asbestos exposure, but a major contribution to asbestos exposure was also provided by sectors with no direct use of asbestos, such as non-asbestos textile industries, metal engineering and construction. A high proportion of cases with environmental exposure was found in clusters where asbestos cement plants were located or a natural source of asbestos (or asbestos-like) fibers was identifiable. Differences in type and sources of exposure can also explain the varying percentage of cases occurring in women among clusters. Conclusions: Our study demonstrates shared exposure patterns in territorial clusters of malignant mesothelioma due to single or multiple industrial sources, with major implications for public health policies, health surveillance, compensation procedures and site remediation programs.
Clinical investigation of former workers exposed to asbestos: the health surveillance experience of an Italian University Hospital

Luigi De Maria,Floriana Pentimone,Domenica Cavone,Antonio Caputi,Stefania Sponselli,Francesco Fragassi,Francesco Dicataldo,Vito Luisi,Giuseppe Delvecchio,Gianmarco Giannelli,Francesco Cafaro,Stefano Sole,Claudia Ronghi,Silvia Zagaria,Giuseppe Loiacono,Gianfranco Sifanno,Giovanni Maria Ferri,Luigi Vimercati

DOI: https://doi.org/10.3389/fpubh.2024.1411910

2024-06-17

Abstract:Background: The need for health surveillance of former workers exposed to asbestos was provided by law in Italy after the asbestos ban in 1992. Objectives: We describe the results of the health surveillance of former workers exposed to asbestos, conducted over 27 years, from 1994 to 2020, at the Operative Unit of Occupational Medicine of the University Hospital of Bari. Materials and methods: We adopted the health surveillance protocol, which was validated at the national level in 2018. Results: A total of 1,405 former workers exposed to asbestos were examined. We proceeded with diagnosing pathologies in 339 cases (24% of the cohort subjected to surveillance), with diagnoses of some cases involving multiple pathologies. Specifically, pleural plaques were diagnosed in 49.2% of the 339 cases, asbestosis in 35.9%, malignant pleural mesothelioma (MPM) in 20.3%, mesothelioma of the vaginal tunic of the testis (MTVT) in 9.1%, lung cancer in 5.8%, and laryngeal cancer in 0.8%. Conclusion: Despite the 1992 asbestos ban, asbestos-related diseases remain a serious public health issue. It is important to establish criteria that ensure the health surveillance of formerly exposed workers minimizes costs, reduces the number of invasive examinations, and optimizes achievable results.
Trends in Asbestos Exposure and Malignant Mesothelioma Incidence in Emilia-Romagna Italy: A Retrospective Study 1996-2023

Fausto Giacomino,Francesco Marinelli,Isabella Bisceglia,Marco Cacchi,Cinzia Storchi,Carmine Pinto,Lucia Mangone,Antonio Romanelli,Fortunato Morabito

DOI: https://doi.org/10.23749/mdl.v115i4.16005

2024-08-27

Abstract:Malignant mesothelioma (MM) is a rare but lethal cancer strongly associated with asbestos exposure. This retrospective study examines trends in asbestos exposure in Emilia-Romagna, Northern Italy. Between 1996 and 2023, 3,513 cases of MM were recorded, predominantly in males (72%) and in older than 65 years (79%). Occupational exposure accounted for 82% of cases, with a significant increase observed over time from 71% to 88% in the most recent period. A greater definition of professional exposure indicates that certain exposure has gone from 49% in the first period to 62% and 58% in the last two periods; probable exposure showed a decrease from 21% to 16% while possible exposure decreased from 16% to 13%. Familiar exposure remained relatively constant at around 8%, environmental exposure showed a slight decrease from 4% to 2%, while non-occupational exposure remained stable at 2%. Among patients with exclusively occupational exposure (1,826 cases), 87% were male and aged between 65 and 75 years (36%) and 75+ (41%). The exposure rates for the province of residence see the province of Reggio Emilia with the highest occupational exposure rate (2.5 x 100,000 residents), followed by Ravenna (2.3 x 100,000 residents) and Parma and Piacenza which have similar exposure rates with 2.2 x 100,000 residents. Professional sectors such as construction, railway maintenance and metalworking are identified as high-risk industries. Despite efforts to mitigate exposure, non-occupational and environmental exposures persist. The study highlights the importance of continuous surveillance and exposure monitoring to guide effective interventions and legal recognition of MM.
The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure

Alessandro Marinaccio,Marisa Corfiati,Alessandra Binazzi,Davide Di Marzio,Alberto Scarselli,Pierpaolo Ferrante,Michela Bonafede,Marina Verardo,Dario Mirabelli,Valerio Gennaro,Carolina Mensi,Gert Schallemberg,Guido Mazzoleni,Enzo Merler,Paolo Girardi,Corrado Negro,Flavia D’Agostin,Antonio Romanelli,Elisabetta Chellini,Stefano Silvestri,Cristiana Pascucci,Roberto Calisti,Fabrizio Stracci,Elisa Romeo,Valeria Ascoli,Luana Trafficante,Francesco Carrozza,Italo Francesco Angelillo,Domenica Cavone,Gabriella Cauzillo,Federico Tallarigo,Rosario Tumino,Massimo Melis,Sergio Iavicoli,E Detragiache,F Merletti,M Gangemi,A Stura,C Brentisci,G Cammarieri Diglio,V Macerata,M Gilardetti,A Lazzarotto,L Benfatto,M Bianchelli,G Mazzucco,Campi,D Malacarne,D Camposeragno,F Di Giorgio,PA Canessa,D Consonni,AC Pesatori,L Riboldi,V Bressan,F Gioffrè,M Ballarinl,C Chermaz,P De Michieli,L Mangone,C Storchi,O Sala,AM Badiali,V Cacciarini,L Giovannetti,A Martini,I Grappasonni,G Masanotti,D D’alo’,Petrucci,M Davoli,F Forastiere,F Cavariani,L Ancona,A Di Giammarco,S Menegozzo,ML Canfora,M Santoro,F Viscardi,A Brangi,V Cozza,L Vimercati,SG Lio,G Cascone,G Frasca,MC Giurdanella,C Martorana,C Nicita,P Rollo,E Spata,G Dardanoni,S Scondotto,V Nieddu,M Pergola,S Stecchi

DOI: https://doi.org/10.1136/oemed-2016-104119

IF: 4.9

2017-12-21

Occupational and Environmental Medicine

Abstract:Introduction The epidemiology of gender differences for mesothelioma incidence has been rarely discussed in national case lists. In Italy an epidemiological surveillance system (ReNaM) is working by the means of a national register. Methods Incident malignant mesothelioma (MM) cases in the period 1993 to 2012 were retrieved from ReNaM. Gender ratio by age class, period of diagnosis, diagnostic certainty, morphology and modalities of asbestos exposure has been analysed using exact tests for proportion. Economic activity sectors, jobs and territorial distribution of mesothelioma cases in women have been described and discussed. To perform international comparative analyses, the gender ratio of mesothelioma deaths was calculated by country from the WHO database and the correlation with the mortality rates estimated. Results In the period of study a case list of 21 463 MMs has been registered and the modalities of asbestos exposure have been investigated for 16 458 (76.7%) of them. The gender ratio (F/M) was 0.38 and 0.70 (0.14 and 0.30 for occupationally exposed subjects only) for pleural and peritoneal cases respectively. Occupational exposures for female MM cases occurred in the chemical and plastic industry, and mainly in the non-asbestos textile sector. Gender ratio proved to be inversely correlated with mortality rate among countries. Conclusions The consistent proportion of mesothelioma cases in women in Italy is mainly due to the relevant role of non-occupational asbestos exposures and the historical presence of the female workforce in several industrial settings. Enhancing the awareness of mesothelioma aetiology in women could support the effectiveness of welfare system and prevention policies.

public, environmental & occupational health
Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis.

G. Agnelli,C. Becattini,T. Kirschstein

DOI: https://doi.org/10.1001/ARCHINTE.162.22.2537

2002-12-09

Archives of Internal Medicine

Abstract:BACKGROUND In patients with acute pulmonary embolism, thrombolysis results in a more rapid resolution of pulmonary emboli than heparin treatment. Whether this advantage results in an improved clinical outcome is unclear. We sought to perform a clinical outcome-based meta-analysis of studies comparing thrombolytic and heparin treatment in patients with pulmonary embolism. METHODS Data concerning adverse outcome events (death, recurrent pulmonary embolism, and major bleeding events) were extracted from the identified randomized studies. RESULTS A total of 56 (23.2%) of 241 patients treated with thrombolytic agents in 9 randomized trials experienced an adverse outcome event compared with 57 (25.9%) of 220 patients treated with heparin (relative risk [RR], 0.9; 95% confidence interval [CI], 0.57-1.32). In the thrombolysis group, 11 patients (4.6%) died compared with 17 (7.7%) in the heparin group (RR, 0.59; 95% CI, 0.27-1.25). Thirty-one patients (12.9%) undergoing thrombolysis had a major bleeding episode compared with 19 patients (8.6%) treated with heparin (RR, 1.49; 95% CI, 0.85-2.81). Five fatal bleeding episodes (2.1%) occurred in the thrombolysis group and none in the heparin group. Six studies provided data on recurrent pulmonary embolism. A recurrence occurred in 14 (6.6%) of 214 patients treated with thrombolytic agents and in 22 (10.9%) of 201 patients treated with heparin (RR, 0.60; 95% CI, 0.29-1.15). Recurrence and/or death occurred in 25 (10.4%) of 241 and in 38 (17.3%) of 220 patients treated with thrombolytic agents and heparin, respectively (RR, 0.55; 95% CI, 0.33-0.96; P =.03). CONCLUSIONS In patients with pulmonary embolism, thrombolysis had a lower composite end point of death/recurrence than heparin treatment. Excessive bleeding is the trade-off for improved efficacy. A comparative clinical outcome trial of thrombolysis and heparin treatment is warranted in patients with pulmonary embolism and selected for high risk of death and/or recurrence and low risk of bleeding.
Asbestos Burden in Lungs of Subjects Deceased From Mesothelioma Who Lived in Proximity to an Asbestos Factory: A Topographic Post‐Mortem SEM‐EDS Study

Silvia Damiana Visonà,Matthew Untalan,Barbara Bertoglio,Silvana Capella,Elena Belluso,Marco Billò,Tara Ivic‐Pavlicic,Emanuela Taioli

DOI: https://doi.org/10.1002/ajim.23680

2024-11-30

American Journal of Industrial Medicine

Abstract:Background Asbestos exposure and its pathological consequences, especially malignant mesothelioma (MM) still represent a major public health problem on a global scale. After the ban of asbestos in most western countries, nonoccupational exposure plays an essential role in MM pathogenesis. However, few studies have quantified asbestos lung burden after environmental exposure. The main objective of this work is to understand if asbestos lung content is different between occupationally and environmentally exposed individuals, and if the distance between the subjects' residences and the source of exposure is significantly associated with the asbestos lung burden. Methods In this retrospective, observational study we quantified, with analytical scanning electron microscopy, asbestos content in lungs of individuals deceased from MM between 2005 and 2019, who were exposed to asbestos (occupationally and/or environmentally) in Broni, a small town in northern Italy where an important asbestos‐cement plant operated until 1993. Results We analyzed asbestos lung content of 77 subjects. We found that the asbestos lung content in MM patients who lived around the asbestos factory was as high as that seen in occupationally exposed individuals; this holds true in residents up to 10 km radius from the factory. We found no significant associations between the residence duration/distance ratio and asbestos lung burden. Conclusions This study suggests that heavy asbestos pollution involves not only the area adjacent to the factory, but the entire town of Broni and the surroundings. This is alarming if we consider that most asbestos factories still active in some countries are located close to towns and dwellings.

public, environmental & occupational health
Asbestos exposure determined 357 days after death through autopsy: a report of a multidisciplinary approach

Giuseppe Davide Albano,Vito Rodolico,Simone Di Franco,Giuseppe Lo Re,Mauro Midiri,Ginevra Malta,Emanuele Cannizzaro,Antonina Argo,Stefania Zerbo

DOI: https://doi.org/10.1007/s12024-024-00838-z

2024-05-30

Forensic Science Medicine and Pathology

Abstract:Asbestosis is an interstitial lung disease caused by the inhalation of asbestos fibers and poses a significant risk to individuals working in construction, shipping, mining, and related industries. In a forensic context, postmortem investigations are crucial for accurate diagnosis, for which the gold standard is the histopathological examination. This case report describes the autopsy and related investigations conducted on an 84-year-old man, nearly one year (357 days) after his death. After a post-mortem CT scan, an autoptic investigation was performed, followed by histopathological, immunohistochemical, and scanning electron microscopy examinations. The integration of the evidence from these examinations with previously available personal and clinical information conclusively confirmed the diagnosis of asbestosis. We demonstrated the efficacy and reliability of our diagnostic protocol in detecting asbestosis and asbestos fibers and excluding mesothelioma even in decomposed tissues. According to our findings autopsy remains the diagnostic gold standard in cases of suspected asbestosis within a forensic context, even 1 year after death, therefore it is always highly recommended, even in cases where the body has decomposed.

pathology,medicine, legal
DNA repair by articular chondrocytes. IV. Measurement of Micrococcus luteus endonuclease-sensitive sites by alkaline elution in rabbit articular chondrocytes

J. Lipman,R. Setlow

DOI: https://doi.org/10.1016/0047-6374(87)90018-2

IF: 5.498

1987-09-30

Mechanisms of Ageing and Development

Abstract:
Pathology analysis for mesothelioma study in the United Kingdom: Current practice and historical development

B. W. Case

DOI: https://doi.org/10.1080/10937404.2016.1195320

2016-08-17

Abstract:Following up on the largest case-control study of malignant mesothelioma yet performed, investigators at the London School of Hygiene and Tropical Medicine assessed 1732 male and 670 female cases as of May 2013. Epidemiological findings of a subset of these were published previously, excluding patients who died or who refused to be interviewed. Pathology reports were collected for subjects, including those both eligible and ineligible for epidemiology study based on vital status. The current investigation examined 860 cases having pathology reports available. Sixty-one cases were diagnosed using cytology only, often with equivocal diagnoses, while 799 reported at least a biopsy of the tumor. Of these, 748 had pathology sufficiently detailed for evaluation. These reports were examined for basis of diagnosis, differences between study cases and ineligible cases, pathology characteristics, and immunohistochemical and other tests used. The most prominent subtype was epithelioid (64% of study cases but only 49% of ineligible cases). Biphasic subtype was present in 10% of study cases and 16% of those ineligible. Sarcomatoid subtype was present in 7% of study cases and 19% of ineligible cases, most of whom died. Twelve percent of study cases displayed no specified subtype, versus 7% of ineligible cases. Of recorded immunohistochemical stains specific for mesothelial cell origin, calretinin (95%) and CK 5/6 or CK5 alone (84%) were by far the most common. Calretinin and CK 5/6 or CK 5 alone were also most sensitive and positive in 92% of cases presenting with surgical pathology report. Ninety percent of cases had at least one immunohistochemical marker for possible lung carcinoma applied, with BER-Ep4 and TTF-1 the most frequent at 68% and CEA at 58%. TTF-1 and CEA were positive in 1% or less of cases. Patterns of use and positive and negative results for each of these as well as other immunohistochemical stains are presented and discussed, along with a brief historical description of their development and use. Possible effects of the pathologic analysis on the results of previously published and future epidemiological studies are discussed.
Identifying malignant mesothelioma by a pathological survey using the São Paulo state hospital cancer registry, Brazil

Fabiola Del Carlo Bernardi 1,Eduardo Algranti2,Marisa Dolhnikoff3,Clóvis Antônio Lopes Pinto4,Ivanir Martins de Oliveira5,Ester Nei Aparecida Martins Coletta6,Eduardo Caetano Albino da Silva7,Adauto José Ferreira Nunes8,Donaldo Botelho Veneziano9,Carolina Terra de Moraes Luizaga10,Ricardo Luiz Lorenzi11,Diego Rodrigues Mendonça e Silva12,Thais Mauad3

DOI: https://doi.org/10.36416/1806-3756/e20230343

2024-04-24

Jornal Brasileiro de Pneumologia

Abstract:Objective: To review the pathological diagnosis of possible cases and/or hidden cases of malignant mesothelioma (MM) between 2000 and 2012 using the Hospital-Based Cancer Registry database in the state of São Paulo, Brazil. Methods: Possible cases were retrieved by assessing the database. Inclusion criteria were being older than 30 years of age and having ICD-O-3 topography and morphology codes related to MM. A board of expert pathologists reviewed the pathology reports and requested paraffin blocks in cases that demanded revision. After staining with calretinin, D2-40, WT-1 (as positive MM markers) and Ber-EP4 and MOC31 (as negative MM markers), cases were divided and studied independently by a pair of pathologists to confirm or discard the diagnosis of MM. Results: Our sample comprised 482 cases from 25 hospitals, and 130 needed further histological revision. We received 73 paraffin blocks with adequate material. After board analysis, there were 9 cases with a definitive diagnosis of MM, improving the diagnostic rate in 12%. Two cases of previously diagnosed MM were discarded by review. Conclusions: Our results confirm that part of MM underdiagnosis and underreporting in Brazil is due to incomplete or mistaken pathological diagnosis.

respiratory system
Collagen alpha1(I) gene (COL1A1) is repressed by RFX family.

P. Sengupta,Yong Xu,Lin Wang,R. Widom,Barbara D. Smith

IF: 5.485

Journal of Biological Chemistry

Abstract:Collagen type I is composed of three polypeptide chains transcribed from two separate genes (COL1A1 and COL1A2) with different promoters requiring coordinate regulation. Our recent publications, centering on COL1A2 regulation, demonstrate that methylation in the first exon of COL1A2 at a regulatory factor for X box (RFX) site (at -1 to +20) occurs in human cancer cells and correlates with increased RFX1 binding and decreased collagen transcription (Sengupta, P. K., Erhlich, M., and Smith, B. D. (1999) J. Biol. Chem. 274, 36649-36655; Sengupta, S., Smith, E. M., Kim, K., Murnane, M. J., and Smith, B. D. (2003) Cancer Res. 63, 1789-1797). In normal cells, RFX5 complex along with major histocompatibility class II transactivator (CIITA) is induced by interferon-gamma to occupy this site and repress collagen transcription (Xu, Y., Wang, L., Buttice, G., Sengupta, P. K., and Smith, B. D. (2004) J. Biol. Chem. 279, 41319-41332). In this paper, we demonstrate that COL1A1 has an RFX consensus binding site surrounding the transcription start site (-11 to +10) that contains three methylation sites rather than one in the COL1A2 gene RFX binding site. RFX1 interacts weakly with the unmethylated COL1A1 site, and binds with higher affinity to the methylated site. RFX1 represses the unmethylated COL1A1 less efficiently than COL1A2. COL1A1 promoter activity is sensitive to DNA methylation and the COL1A1 gene is methylated in human cancer cells with coordinately decreased collagen expression. The DNA methylation inhibitor, 5-aza-2'-deoxycytidine (aza-dC) increases collagen gene expression with time in human cancer cells. On the other hand, RFX5 interacts with both collagen type I genes with a similar binding affinity and represses both promoters equally in transient transfections. Two dominant negative forms of RFX5 activate both collagen genes coordinately. Finally, CIITA RNA interference experiments indicate that CIITA induction is required for interferon gamma-mediated repression of both collagen type I genes.
The Pleural Mesothelioma Cases and Mortality in Portugal in 2014–2020: A Descriptive Study

Cátia Santos,Ema Sacadura-Leite,Joana Ferreira,Maria dos Anjos Dixe,Philippe Astoul,António Sousa-Uva

DOI: https://doi.org/10.3390/healthcare12111103

2024-05-28

Health Care

Abstract:Background: The incidence and mortality of pleural mesothelioma (PM) reflect the production and consumption of asbestos over time. However, despite the current global concern, these data remain to be known. Objective: Our aim was to carry out a descriptive analysis of PM cases and mortality from some Portuguese databases between 2014 and 2020. Methods: A retrospective observational study was carried out between 2014 and 2020. Data on the number of PM cases were provided by the Portuguese Cancer Registry, and data on mortality were from the Portuguese Death Certificate Information System. Results: Between 2014 and 2020, 315 cases of PM were reported, with 222 (70.5%) men. The average age of patients was 72.1, with the highest number of cases in patients aged >70 years (n = 198; 62.9%). The highest number of cases was reported in 2018 (n = 62; 19.7%). Regarding mortality, 169 deaths were reported, with 126 (74.6%) men and mostly in individuals aged >70 years (n = 109; 64.5%). It is estimated that around 520 years of potential life were lost. The highest number of deaths occurred in 2015 (n = 33; 19.5%). Conclusion: It is mandatory to reinforce the need for surveillance programs that allow us to gather real and reliable data and eliminate asbestos-related diseases.

health care sciences & services,health policy & services
Lung fibre burden and risk of malignant mesothelioma in shipyard workers: a necropsy-based case–control study

Dario Mirabelli,Anna Benedetta Somigliana,Danila Azzolina,Dario Consonni,Pietro Gino Barbieri

DOI: https://doi.org/10.1093/annweh/wxae018

IF: 2.779

2024-03-26

Annals of Work Exposures and Health

Abstract:Abstract Objectives In Italy, the highest pleural cancer mortality and incidence have been observed among Italian regions where the 2 largest Italian shipyards were (and are) located. The objective of this study was to assess the exposure–response relationship for mesothelioma among male workers employed in the Monfalcone, Italy, shipyard. Methods We conducted a necropsy-based case–control study. Cases (N = 102) were mesothelioma decedents and controls were those with lung cancer (N = 84). Complete job histories were available; the lung fibre content was measured using a scanning electron microscope with X-ray fluorescence, after sample preparation according to the European Respiratory Society guidelines. Odds ratios and 95% confidence intervals of mesothelioma by fibre type and lung fibre burden, as a categorical or continuous variable, were assessed by unconditional logistic regression, adjusted for age and time since exposure cessation. Analyses for the amphibole and chrysotile lung fibre burden were mutually adjusted. We calculated a cumulative exposure index by applying a job-exposure matrix to the job histories of study cases and assessed its correlation with the lung fibre burden. Results We found an odds ratio of 22.0 (confidence intervals 5.66–85.7) for the highest lung fibre burden category (mean 43.8 million total asbestos fibres per gram of dry tissue) compared with the reference (mean 0.48). Using log10-transformed lung fibre burden, we found that the odds ratio was 3.71 (confidence intervals 2.03–6.79) for a 10-fold lung fibre burden increase. Results for the amphibole lung fibre burden were similar. Odds ratios increased over chrysotile lung fibre burden categories (P-trend = 0.025), and the odds ratio for a 10-fold increase was 4.73 (confidence intervals 0.32–70.4). Conclusions The cumulative exposure index was correlated with total and amphibole lung fibre burden, but not with chrysotile lung fibre burden. Mesothelioma risk was proportional to total, amphibole, and chrysotile lung fibre burden in shipyard workers.

public, environmental & occupational health
The relationship between malignant mesothelioma and an asbestos cement plant environmental risk: a spatial case-control study in the city of Bari (Italy)

Marina Musti,Alessio Pollice,Domenica Cavone,Silvano Dragonieri,Massimo Bilancia

DOI: https://doi.org/10.1007/s00420-008-0358-5

Abstract:Objectives: To estimate the mesothelioma risk and environmental asbestos exposure (EAE) due to an asbestos-cement plant. Methods: A spatial case-control study including 48 malignant mesothelioma (MM) cases occurred in the period 1993-2003 selected from the regional mesothelioma register (RMR) and 273 controls. The disease risk was estimated by means of a logistic-regression model, in which the probability of disease-occurrence is expressed as a function of the classes of distances. A non-parametric method was applied to estimate the full relative risk surface. Results: Significant MM odds ratio of 5.29 (95 CI: 1.18-23.74) was found for people living within a range up to 500 m centered on the plant. The non-parametric estimation of relative risk surface unveiled a marked peak near the plant not paralleled by the spatial distribution of controls. Conclusion: Evidence of an association between mesothelioma risk and EAE is highlighted. The role played by the RMR in increasing the public health local authorities awareness is stressed.
The role of MicroRNAs as early biomarkers of asbestos-related lung cancer: A systematic review and meta-analysis

D Mukhopadhyay,P Cocco,S Orrù,R Cherchi,S De Matteis,D. Mukhopadhyay,P. Cocco,S. Orrù,R. Cherchi,S. De Matteis

DOI: https://doi.org/10.1016/j.pulmoe.2024.02.002

IF: 11.7

2024-02-01

Pulmonology

Abstract:BACKGROUND: Asbestos is still the leading cause of occupational cancer mortality worldwide. Asbestos-related lung cancer (LC) and malignant pleural mesothelioma (MPM) prognosis is still poor especially at advanced stage, so early diagnosis biomarkers are needed. MicroRNAs (miRNAs) have been proposed as potential early diagnostic biomarkers of asbestos-related LC and MPM.AIM: To evaluate the role of miRNAs as diagnostic and prognostic biomarkers of asbestos-related LC and MPM by performing a literature systematic review and meta-analysis.METHODS: MEDLINE, EMBASE via Ovid, PUBMED and Cochrane library databases were systematically searched up to April 2023 to identify relevant articles. A grey literature search was also conducted using the Google Scholar platform. MeSH and free text terms for 'asbestos', 'occupational exposure', 'lung cancer', 'mesothelioma' and 'miRNAs' were used to search the literature. Our systematic review protocol was registered in the PROSPERO database. Study quality was assessed via the Newcastle-Ottawa Scale.RESULTS: From the search, 331 articles were retrieved, and, after applying our selection criteria, and exclusion of one study for poor quality, 27 studies were included in the review. Most of the studies were hospital-based case-control, conducted in Europe, and evaluated MPM among men only. MiRNAs expression was measured mainly in plasma or serum. MiR-126, miR-132-3p, and miR-103a-3p were the most promising diagnostic biomarkers for MPM, and we estimated a pooled area under the curve (AUC) of 85 %, 73 %, and 50 %, respectively. In relation to MPM prognosis, miR-197‑3p resulted associated with increased survival time. MiR-126, alone and combined with miR-222, was confirmed associated also to LC diagnosis, together with miR-1254 and miR-574-5p; no miRNA was found associated to LC prognosis.CONCLUSION: Based on our systematic literature review there is suggestive evidence that the expression of specific miRNAs in the blood serum or plasma are associated with asbestos-related LC and MPM diagnosis and prognosis. Further large longitudinal studies are urgently needed to validate these findings and elucidate the underlying mechanisms given the potential important implications for patients' survival.

respiratory system
The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis

Sonja Klebe,Yukio Nakatani,Katalin Dobra,Kelly J Butnor,Anja C Roden,Andrew G Nicholson,Alberto M Marchevsky,Aliya N Husain,Amanda Segal,Ann E Walts,Birgit Weynand,Claire W Michael,Sanja Dacic,David Godbolt,Richard Attanoos,Eric Santoni-Rugiu,Françoise Galateau-Salle,Kenzo Hiroshima,Andre L Moreira,Juliet Burn,Kazuki Nabeshima,Allen R Gibbs,Andrew Churg,Leslie A Litzky,Luka Brcic,Ming Sound Tsao,Mari Mino-Kenudson,Sara B Rørvig,Henry D Tazelaar,Thomas Krausz,Yu Zhi Zhang,Lucian R Chirieac,Mary B Beasley,Anders Hjerpe,Kelly J. Butnor,Anja C. Roden,Andrew G. Nicholson,Alberto M. Marchevsky,Aliya N. Husain,Ann E. Walts,Claire W. Michael,Andre L. Moreira,Allen R. Gibbs,Leslie A. Litzky,Sara B. Rørvig,Henry D. Tazelaar,Lucian R. Chirieac,Mary B. Beasley

DOI: https://doi.org/10.1016/j.pathol.2020.12.005

IF: 5.335

2021-06-01

Pathology

Abstract:<h2 class="section-title u-h3 u-margin-l-top u-margin-xs-bottom">Summary</h2><p>Diffuse malignant mesothelioma (MM) is an incurable tumour of the serosal membranes, which is often caused by exposure to asbestos and commonly diagnosed at advanced stage. Malignant mesothelioma <em>in situ</em> (MMIS) is now included as diagnostic category by the World Health Organization (WHO). However, our international survey of 34 pulmonary pathologists with an interest in MM diagnosis highlights inconsistency regarding how the diagnosis is being made by experts, despite published guidelines. Whilst the WHO restricts the diagnosis to surgical samples, the very concept has implication for cytological diagnosis, which is already regarded as controversial in itself by some. MMIS is currently only applicable as precursor to MM with an epithelioid component, and raises the possibility for different molecular pathways for different histological MM subtypes. The clinical implications of MMIS at this stage are uncertain, but aggressive therapies are being initiated in some instances. Based on the results of the survey we here present a critical appraisal of the concept, its clinical and conceptual implications and provide practice suggestions for diagnosis. A low threshold for ancillary testing is suggested. The designations of 'malignant mesothelioma, cannot exclude MMIS' or 'atypical mesothelial proliferation with molecular indicators of malignancy, so-called MMIS' could be used on cytology samples, adding 'no evidence of invasion in sample provided' for surgical samples. Clinical and radiological correlation are integral to diagnosis and best done at multidisciplinary meetings. Finally, collaborative studies are required to improve our understanding of MMIS.</p>

pathology
Editorial: Epigenetic Modifications in Mesothelioma

Y. Cheng,M. Yuen,Hongchuan Jin

DOI: https://doi.org/10.3389/fonc.2021.650136

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:We are pleased to announce the publication of this Research Topic focusing on epigenetic modifications in mesothelioma. Epigenetic modification has been investigated for the past two decades. It is a key process of cellular development as well as carcinogenesis. Mesothelioma is an aggressive cancer caused by asbestos exposure and currently has very limited effective treatment options. Epigenetic modification in mesothelioma is an emerging field which will provide fundamental information for diagnosis and treatment of mesothelioma. We believe that, as for other cancers, if we can detect this cancer at an as early stage as possible, then we can significantly increase survival time as well as select suitable treatments for the patients. Currently, misdiagnosis and delayed treatment jeopardises patient survival and quality of life. Mesothelioma is one of the most difficult cancers to diagnose, due to symptoms closely resembling lung cancer and other lung diseases. The most discussed topics in this Research Topic are biomarkers and how to diagnose mesothelioma. Rozitis et al. discuss the current methods used to diagnose mesothelioma. The take home message of this review is that at least nine immunohistochemistry biomarkers are used in the clinical setting to facilitate mesothelioma diagnosis. A tissue or cytology sample is normally required for definitive diagnosis. The authors mention the necessity to further develop epigenetic biomarkers to facilitate clinical diagnosis. A novel class of biomarker - the “circular RNA” is also discussed in the review. The review provides the basis of how mesothelioma is currently diagnosed and reviews emerging epigenetic biomarkers in mesothelioma. Although DNA methylation is the most discussed epigenetic biomarker in other cancers, microRNA represents the most interesting for mesothelioma researchers. Tomasetti et al. focus on microRNA as an early diagnosis biomarker for mesothelioma. The authors cover how reactive oxygen species (ROS) induced from asbestos can cause epigenetic alterations and aberrant gene expression. MicroRNAs are stable and amenable for treatment development. Unlike protein-coding genes in gene replacement therapy, microRNAs are small and more easily to restore their “cancer killer” functions. More importantly, the authors discuss microRNA replacement therapy in mesothelioma for which there has been one on-going clinical trial. We believe this review will trigger further development of microRNA replacement to treat mesothelioma. Biomarkers that facilitate other treatment options leading to better outcomes in mesothelioma are another emerging area of discussion. Yoshikawa et al. research the benefits of epigenetic alterations and its potential in advancing the response to immune checkpoint PD-1 inhibitor nivolumab. The authors describe recent knowledge on epigenetic alterations, which identify potential candidate therapeutic targets and immunotherapeutic regimens under development for MPM. Being a disease that is difficult to diagnose, researchers have tried various biomarkers that are anticipated to improve mesothelioma diagnosis. CDKN2A fluorescence in-situ hybridization is one of the biomarkers used in a clinical setting to facilitate differential mesothelioma diagnosis. Cheng et al. re-validate CDKN2A and MTAP, which are usually co-deleted in mesothelioma, in a large cohort of MPM patient samples. The authors promote the use of droplet digital PCR (ddPCR) as an alternative to study these two biomarkers in mesothelioma. Amongst all the epigenetic biomarkers discussed in the special edition, circulating biomarker is frequently explored because of its advantage in requiring less-invasive detection routes. With the development of new detection methods, biomarkers that provide high sensitivity and specificity can easily be further investigated for their clinical applications. Epigenetic biomarkers such as DNA methylation, microRNA and non-coding RNA have high potential to provide sensitive and specific detection of mesothelioma as well as providing earlier possible detection. Epigenetic regulation is a rewarding area of study, as it is involved in almost all developmental processes including the early stage of cancers. Different epigenetic signatures can be used to identify different stages of cancer development. This makes it relatively useful for further development for early detection of mesothelioma. Due to a long latency period from asbestos exposure to development of mesothelioma, most patients are diagnosed at a late stage of the disease when very limited treatment options are available for effective outcomes. Early detection utilizing epigenetic biomarkers to identify mesothelioma will be beneficial for this deadly disease. Epigenetic biomarkers have great potential to become more conclusive diagnostic and prognostic biomarkers for mesothelioma. The development of new technologies will also largely facilitate biomarker detection sensitivity. However, further research is required in this field to ensure the widespread application of epigenetic biomarkers in clinical settings. In conclusion, epigenetic regulation plays a major role in mesothelioma and holds great potential to become clinically relevant in mesothelioma. More studies are required to further develop and validate the clinical applications of epigenetic biomarkers in mesothelioma.
[FREQUENCY OF CONCEPTION AND THE COURSE OF PREGNANCY. RESEARCH AND CALCULATION OF THE INCIDENCE OF CRIMINAL ABORTION SINCE 1940].

H. Hoffmeyer,M. Nørgaard

1964-03-12

Abstract:
Biomarkers for detecting malignant pleural mesothelioma: Protocol for a reanalysis of published data based on systematic reviews of diagnostic test accuracy.

Xiangyi Zan,Yuping Wang,Junnian Shi,Lanting Zhao,Yan Zhao,Rong Liu,Yongning Zhou,Yixin Wan

DOI: https://doi.org/10.1097/MD.0000000000016028

IF: 1.6

2019-01-01

Medicine

Abstract:Background: Malignant pleural mesothelioma (MPM) is a highly invasive tumor caused primarily by asbestos exposure. In recent decades, the incidence of MPM has shown an increasing trend, posing a great threat to human health. Although there is currently no effective way to treat MPM, patients can survive for more than 5 years if the tumor is removed early. Several systematic reviews (SRs) have evaluated the diagnostic value of biomarkers for diagnosing MPM. However, no studies have been conducted to analyze the quality of these SRs and it remains unclear which biomarker is the excellent diagnostic test. This study aims to assess the methodological quality of the SRs and reanalyze the published data based on SRs to find the optimal biomarker for the early diagnosis of MPM. Methods: A systematic search will be performed in PubMed, Embase.com, the Cochrane Library of Systematic Reviews, and Web of Science to identify SRs reporting value of biomarkers for detecting MPM. We will evaluate the risk of bias of the included SRs according to the Assessment of Multiple Systematic Reviews-2 (AMSTAR-2) instrument. Standard pairwise meta-analysis and adjusted indirect comparison will be used to compare the diagnostic value of different biomarkers. Results: The results of this study will be submitted to a peer-reviewed journal for publication. Conclusion: This study will reanalyze the published data based on SRs to find a biomarker with the superior diagnostic performance for the diagnosis of MPM. Ethics and dissemination: Ethics approval and patient consent are not required as this study is an overview based on published systematic reviews.
Translation, Cultural Adaptation, and Content Validation of a Pleural Mesothelioma Questionnaire to Portuguese Context – A Key Tool for Epidemiological Surveillance

Cátia Santos,Ema Sacadura-Leite,Salvato Feijó,Maria dos Anjos Dixe,Philippe Astoul,António Sousa-Uva

DOI: https://doi.org/10.1159/000538097

2024-04-08

Portuguese Journal of Public Health

Abstract:Objective: The main objective of this study was to describe the translation, cultural adaptation, and content validation process of the French National Surveillance Programme for Pleural Mesothelioma (FNSPPM) questionnaire for the Portuguese context. Methods: A search was conducted in the PubMed database and Web of Science, in the period from January 1, 1960, to December 31, 2022, to select the questionnaire. Forward and reverse translations, calculation of the content validity index (CVI) by a panel of experts ( n = 9), and cognitive interviewing with individuals with at least one exposure to asbestos ( n = 10) were performed. Experts rated items on a Likert scale (1-4) based on their relevance. The item-level content validity index (I-CVI), scale-level content validity index based on the average method (S-CVI/Ave), and scale-level content validity index based on the universal agreement method (S-CVI/UA) were calculated. Results: The final version of the FNSPPM questionnaire for the Portuguese context resulted from a translation and content validation process. The panel of experts considered the questionnaire relevant, with an I-CVI of up to 0.78 in 68 of 69 of the questions, an S-CVI/Ave of 0.98, and an S-CVI/UA of 0.90. The participants in the cognitive interviews reported an understanding of the questionnaire. Conclusion: A validated FNSPPM questionnaire for the Portuguese context is now available to study individuals with pleural mesothelioma (PM) and asbestos exposure.

[Controlled trials on the use of thiamphenicol glycinate and acetylcysteine. Mucoelastographic tests and clinico-therapeutic trials].

Epidemiological patterns of asbestos exposure and spatial clusters of incident cases of malignant mesothelioma from the Italian national registry

Clinical investigation of former workers exposed to asbestos: the health surveillance experience of an Italian University Hospital

Trends in Asbestos Exposure and Malignant Mesothelioma Incidence in Emilia-Romagna Italy: A Retrospective Study 1996-2023

The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure

Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis.

Asbestos Burden in Lungs of Subjects Deceased From Mesothelioma Who Lived in Proximity to an Asbestos Factory: A Topographic Post‐Mortem SEM‐EDS Study

Asbestos exposure determined 357 days after death through autopsy: a report of a multidisciplinary approach

DNA repair by articular chondrocytes. IV. Measurement of Micrococcus luteus endonuclease-sensitive sites by alkaline elution in rabbit articular chondrocytes

Pathology analysis for mesothelioma study in the United Kingdom: Current practice and historical development

Identifying malignant mesothelioma by a pathological survey using the São Paulo state hospital cancer registry, Brazil

Collagen alpha1(I) gene (COL1A1) is repressed by RFX family.

The Pleural Mesothelioma Cases and Mortality in Portugal in 2014–2020: A Descriptive Study

Lung fibre burden and risk of malignant mesothelioma in shipyard workers: a necropsy-based case–control study

The relationship between malignant mesothelioma and an asbestos cement plant environmental risk: a spatial case-control study in the city of Bari (Italy)

The role of MicroRNAs as early biomarkers of asbestos-related lung cancer: A systematic review and meta-analysis

The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis

Editorial: Epigenetic Modifications in Mesothelioma

[FREQUENCY OF CONCEPTION AND THE COURSE OF PREGNANCY. RESEARCH AND CALCULATION OF THE INCIDENCE OF CRIMINAL ABORTION SINCE 1940].

Biomarkers for detecting malignant pleural mesothelioma: Protocol for a reanalysis of published data based on systematic reviews of diagnostic test accuracy.

Translation, Cultural Adaptation, and Content Validation of a Pleural Mesothelioma Questionnaire to Portuguese Context – A Key Tool for Epidemiological Surveillance